Morepen Laboratories Limited has submitted a formal clarification to BSE Limited in response to their email dated 10th June 2026 with reference number L/SURV/ONL/PV/SG/2026-2027/125 regarding unusual price movement and trading volume in the company's shares.
The company confirms that it has been regularly intimating all compliance matters to Stock Exchanges as required under Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended.
Specifically, Morepen Laboratories states that there are no pending announcements, events, or information that qualify as price-sensitive and that could have led to the significant increase in trading volume observed in the company's shares.
The company attributes the increased volume in its shares to market-driven factors rather than any company-specific undisclosed developments.